Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Alligator Bioscience AB
Industry Sector: HealthTechnology
CEO: Søren Bregenholt, PhD
Number Of Employees: 46
Enterprise Value: $14,753,153
PE Ratio: -0.2
Exchange/Ticker 1: SSE:ATORX
Exchange/Ticker 2: N/A
Latest Market Cap: $4,971,894
BioCentury | Feb 27, 2025
Product Development
Pancreatic cancer therapies progress despite mixed investor response
BioCentury’s latest clinical report highlights therapies that extended pancreatic cancer survival
BioCentury | Jan 31, 2024
Product Development
Clinical roundup: Data for Vertex, Sarepta, Lilly, Alligator, Corbus and Vera
Vertex’s analgesic heads for submission; plus the latest from Sarepta in DMD, Lilly in hearing loss, and more
BioCentury | May 26, 2021
Targets & Mechanisms
ASCO readouts offer early hints of efficacy for 4-1BB antibodies
A trio of first-in-human readouts for 4-1BB agonistic antibodies point to clinical progress for the challenging checkpoint
BioCentury | Dec 31, 2020
Management Tracks
Biden-Harris team picks coordinators for COVID-19 task force; plus moves at Taysha, Alligator and ImmunityBio
President-elect Joe Biden and Vice President-elect Kamala Harris named coordinators for three key posts on the incoming administration’s COVID-19 response team to manage the supply chain,
BioCentury | Dec 5, 2020
Product Development
Bispecifics spring ahead at this year’s ASH, SITC
First-in-human results at fall conferences reveal rapid expansion in the target space for bispecifics
BioCentury | Dec 4, 2019
Company News
Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more
BioCentury | Aug 22, 2019
Company News
Aug. 21 Company Quick Takes: GSK, FibroGen take regulatory steps forward for HIF-PH inhibitors in Asia; plus Xtandi, Biotheus/Alligator and more
BioCentury | Jul 31, 2019
Company News
July 31 Company Quick Takes: Bayer, Orion win approval in prostate cancer; plus Keytruda, Roche-Spark, UC v. Broad and more
BioCentury | Jun 1, 2019
Product Development
ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts
BioCentury’s analysis of ASCO 2019 abstracts shows bispecifics outpacing CAR Ts in solid tumors
BioCentury | Apr 26, 2018
Product R&D
Brake for gas
China newco Elpiscience links 4-1BB boost to PD-L1 block in first of 12 programs
Items per page:
1 - 10 of 28